Deletion of CD74, a putative MIF receptor, in mice enhances osteoclastogenesis and decreases bone mass

scientific article

Deletion of CD74, a putative MIF receptor, in mice enhances osteoclastogenesis and decreases bone mass is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/JBMR.1787
P932PMC publication ID3563845
P698PubMed publication ID23044992

P2093author name stringHee Yeon Won
Sun-Kyeong Lee
Se Hwan Mun
Paula Hernandez
Hector Leonardo Aguila
P2860cites workEssential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1Q24300916
MIF signal transduction initiated by binding to CD74Q24303802
CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complexQ24307384
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activationQ24311588
TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cellsQ24315251
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell functionQ24336057
RANK is essential for osteoclast and lymph node developmentQ24598872
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligandQ24653311
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKLQ24682139
Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseQ26778460
Multilineage potential of adult human mesenchymal stem cellsQ27860737
Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1Q28138425
MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemiaQ28265011
Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesisQ28267970
Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinaseQ28278061
The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptorQ28285539
RANKL-RANK signaling in osteoclastogenesis and bone diseaseQ28287091
Insight into the biology of macrophage migration inhibitory factor (MIF) revealed by the cloning of its cell surface receptorQ28297046
Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expressionQ28585705
Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid actionQ28594433
Osteoclast differentiation and activationQ29547556
Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature CommitteeQ29616160
Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclastsQ29618116
Polarized expression of CD74 by gastric epithelial cellsQ30414247
Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyteQ33858422
Evolution of the CD8 T-cell repertoire during infectionsQ34019945
Differentiation and function of osteoclastsQ35113943
Modulation of osteoclast differentiationQ35957509
Osteoblast-specific overexpression of human interleukin-7 rescues the bone mass phenotype of interleukin-7-deficient female miceQ35992094
Isoforms of the invariant chain regulate transport of MHC class II molecules to antigen processing compartmentsQ36236708
Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptorsQ36375584
Advances in bone biology: the osteoclastQ36825193
CD74 in antigen presentation, inflammation, and cancers of the gastrointestinal tractQ37234000
Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiationQ37286240
NFATc1: functions in osteoclastsQ37662853
Guidelines for assessment of bone microstructure in rodents using micro-computed tomographyQ37763651
CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune diseaseQ37826194
Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-FosQ38342636
Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulatorQ38363724
Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activityQ40169158
Participation of phospholipase D and alpha/beta-protein kinase C in growth factor-induced signalling in C3H10T1/2 fibroblastsQ40643082
Regulation of osteoclastogenesis and RANK expression by TGF-beta1.Q40778414
Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigensQ41376430
Alterations of macrophage functions by mediators from lymphocytesQ41815135
Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formationQ42475736
Enhancement of macrophage migration inhibitory factor (MIF) expression in injured epidermis and cultured fibroblasts.Q42479982
Bifurcation of osteoclasts and dendritic cells from common progenitorsQ43757343
Lipopolysaccharide supports survival and fusion of preosteoclasts independent of TNF-alpha, IL-1, and RANKL.Q43864464
The surface antigen CD45R identifies a population of estrogen-regulated murine marrow cells that contain osteoclast precursorsQ44480297
Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activityQ46669596
Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival.Q53636101
RANKL-stimulated osteoclast-like cell formation in vitro is partially dependent on endogenous interleukin-1 production.Q53647336
Macrophage migration inhibitory factor inhibits osteoclastogenesis.Q54473878
The Ii41 isoform of invariant chain mediates both positive and negative selection events in T-cell receptor transgenic mice.Q54662060
RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-βQ57675150
Differential expression of the invariant chain in mouse tumor cells: relationship to B lymphoid developmentQ70459353
Generation of CD1+RelB+ dendritic cells and tartrate-resistant acid phosphatase-positive osteoclast-like multinucleated giant cells from human monocytesQ71775766
Identification of macrophage migration inhibitory factor in murine neonatal calvariae and osteoblastsQ71868864
CFU-GM-derived cells form osteoclasts at a very high efficiencyQ73445414
Basic fibroblast growth factor induces osteoclast formation in murine bone marrow culturesQ74472384
Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharideQ74518854
Expression of macrophage migration inhibitory factor in different stages of human atherosclerosisQ77857409
Identification of multiple osteoclast precursor populations in murine bone marrowQ81628327
P433issue4
P304page(s)948-959
P577publication date2013-04-01
P1433published inJournal of Bone and Mineral ResearchQ15750941
P1476titleDeletion of CD74, a putative MIF receptor, in mice enhances osteoclastogenesis and decreases bone mass
P478volume28

Reverse relations

cites work (P2860)
Q37702522A novel osteoporosis model with ascorbic acid deficiency in Akr1A1 gene knockout mice.
Q41576045CD74-Downregulation of Placental Macrophage-Trophoblastic Interactions in Preeclampsia
Q47373904Clinically Relevant Concentrations of Ketamine Inhibit Osteoclast Formation In Vitro in Mouse Bone Marrow Cultures
Q33912625Contradictory Role of CD97 in Basal and Tumor Necrosis Factor-Induced Osteoclastogenesis In Vivo
Q46260785DJ-1 controls bone homeostasis through the regulation of osteoclast differentiation
Q34788649Effects of salubrinal on development of osteoclasts and osteoblasts from bone marrow-derived cells
Q36489227Hajdu Cheney Mouse Mutants Exhibit Osteopenia, Increased Osteoclastogenesis, and Bone Resorption
Q35790946Knee loading protects against osteonecrosis of the femoral head by enhancing vessel remodeling and bone healing
Q39848278Macrophage Migration Inhibitory Factor (MIF) Supports Homing of Osteoclast Precursors to Peripheral Osteolytic Lesions
Q46274917Macrophage Migration Inhibitory Factor Induces Inflammation and Predicts Spinal Progression in Ankylosing Spondylitis.
Q30586409Macrophage migration inhibitory factor down-regulates the RANKL-RANK signaling pathway by activating Lyn tyrosine kinase in mouse models
Q91026071Macrophage migration inhibitory factor increases atrial arrhythmogenesis through CD74 signaling
Q35163701Macrophage migration inhibitory factor is essential for osteoclastogenic mechanisms in vitro and in vivo mouse model of arthritis
Q53225768Psychosine inhibits osteoclastogenesis and bone resorption via G protein-coupled receptor 65.
Q55226585Regulation of Osteoclast Differentiation by Cytokine Networks.
Q33894821eIF2α signaling regulates ischemic osteonecrosis through endoplasmic reticulum stress

Search more.